1/ Here's my review on adaptive immunity to COVID-19 and SARS-CoV-2. I hope you find it useful. It was a lot of work. Thanks to Prof Alex Sette @SetteLab and others for direct contributions and broader input over the year! cell.com/cell/fulltext/…@CellCellPress
2/ And thanks to all of the amazing scientists and labs around the world that have done so much work making incredible progress on these challenging COVID-19 immunology topics in the past year!
3/ FYI, here's the right version of Figure 1. It should be updated in the next version posted online.
Adding to this. I have been asked for clean copies of Figure 2 for people to use in slide presentations. Here it is, feel free to use.
2/ Definitely good news to see these data on the Pfizer vaccine working against the 501 variant. If anything, the vaccine works better against this variant. biorxiv.org/content/10.110…
3/ It isn't the end of the story, because the UK / SA variants have mutations in addition to 501, but these vaccine data are an important piece of the puzzle. As noted in the article, more is expected from labs in the coming weeks, but these results are expected & encouraging.
1/ One pre-print on B117 viral loads (i.e., B.1.1.7 SARS-CoV-2 ) found substantially higher viral loads (median 10-100 times). Another UK study found 3 times higher viral loads in people with B117 (Bonsall/Golubchik study). medrxiv.org/content/10.110…
2. The immune system can remember viruses. And there are multiple different parts of the immune system that can remember a virus in different ways, so the immune system can fight the virus in multiple ways.
3. Our data shows that the body’s immune system remembers novel coronavirus for at least 8 months after COVID-19, and multiple different branches of the immune system remember the virus.
1. I am convinced that the new "UK variant" of SARS-CoV-2 (B.1.1.7) is a big problem. I look forward to seeing more epidemiology by more labs (not my area), but the overall picture plus these new viral load data now have me convinced. (my PhD was RNA virology)
Thread
2. An analysis of 641 COVID-19 cases found "S-negative" (B.1.1.7 inferred) cases had 10 to 100-times higher nasal viral loads than 'regular' COVID-19. Virologically, that is a massive difference. It could easily explain higher transmissibility. doi.org/10.1101/2020.1…
3. The authors of that work are appropriately cautious in their interpretations (e.g. they didn't directly sequence confirm B.1.1.7 cases), and it will be very valuable to see similar studies from other sites. But, I find the data compelling.
Got lots of interest in my RNA vaccine explainer yesterday. The most common follow up questions generally fell into two categories, well stated in the tweet below. I will answer both. 1/5
First, to paraphrase: “Isn’t it strange for the immune system to deal with a viral protein from RNA in host cells?” Actually, the human immune system has spent millions of years evolving to recognize viruses this way. (Really, vertebrates have spent 500 million years doing this!)
Viruses regularly express their proteins on infected human cells, and the immune system specifically recognizes those foreign viral molecules. Indeed, many viruses are RNA viruses (they use RNA as their genetic material!), so the immune system is specifically good at this job.